- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Focus on Women's Health
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
People
Linda Lorenat focuses on general corporate and securities law matters and transactions, particularly for emerging growth companies in the technology and life sciences industries. As a partner in our Mergers & Acquisitions practice, Linda represents entrepreneurs and emerging growth companies, the investors who fund them and the investment banks and the financial advisors who advise them.
Linda represents issuers and venture capital and strategic investors in the initial formation, financing and sale of technology and life sciences companies. Linda's experience with general company representation also includes advising on employment and equity compensation matters, fiduciary duties, commercial agreements and compliance with federal and state securities laws. Her corporate transactional experience includes representing issuers and investors in convertible debt and preferred stock financings, mergers and acquisitions, public offerings and financings, recapitalizations, spin-outs and strategic transactions.
In 2016, Legal 500 recognized Linda in the category of M&A/Corporate and Commercial—Venture Capital and Emerging Companies.
Credentials
J.D., Santa Clara University School of Law
B.A., Santa Clara University
California
Close
Recognition
M&A/Corporate and Commercial—Venture Capital and Emerging Companies
Legal 500, 2016
News
Recognition
July 8, 2016
Legal 500 U.S. Ranks King & Spalding Practices and Lawyers Among the Best in 2016
Press Release
March 17, 2015
Emerging-Companies Lawyer Linda Lorenat Joins King & Spalding in Silicon Valley
News
Recognition
July 8, 2016
Legal 500 U.S. Ranks King & Spalding Practices and Lawyers Among the Best in 2016
Press Release
March 17, 2015
Emerging-Companies Lawyer Linda Lorenat Joins King & Spalding in Silicon Valley
News
Recognition
July 8, 2016
Legal 500 U.S. Ranks King & Spalding Practices and Lawyers Among the Best in 2016
Press Release
March 17, 2015
Emerging-Companies Lawyer Linda Lorenat Joins King & Spalding in Silicon Valley
Credentials
J.D., Santa Clara University School of Law
B.A., Santa Clara University
California
Close
Recognition
M&A/Corporate and Commercial—Venture Capital and Emerging Companies
Legal 500, 2016